Life-science briefing: Monday, March 31, 2008
TODAY’S HEADLINES:
Boston Scientific spinout TriVascular2 takes in $65M (release)
Inhaled-drug startup Transave raises $35M (release)
Triage Wireless gets $20M for vital-signs monitors (release)
Tryton Medical receives $14M for “bifurcation” stents (release)
Synthetic bio startup Codon Devices adds $11M (release)
Tracon Pharma takes in $4.5M against cancer and eye disease (VentureWire)
Antibody maker… Continue Reading
VisionCare’s implantable microtelescope — a bionic eye for AMD-related blindness
An implantable and odd-looking microtelescope from a Saratoga, Calif., device maker could be one of the next big things in treating a common form of blindness — assuming that patients are willing to endure arduous surgery in order to obtain their new bionic eyes.
Age-related macular… Continue Reading
Boston Scientific acquires medical-wireless startup Remon Medical
Boston Scientific agreed to acquire Remon Medical Technologies, an Israeli maker of wireless technology for communicating with implanted medical devices. The companies didn’t disclose financial terms; their release is here.
Founded in 1997, Remon struck a co-development deal with Guidant in 2004. Boston Scientific acquired Guidant… Continue Reading
Neuromodulator Intelect Medical raises $7M for brain disorders
Intelect Medical, a Cleveland developer of neuromodulation devices for the treatment of brain injury, raised $7 million in a second funding round. The company is currently exploring ways of using deep-brain stimulation, in which implanted electrodes zap particular regions of the brain with calibrated jolts… Continue Reading
Asthma-device maker Asthmatx sells $50M stake to Olympus
Asthmatx, a Mountain View, Calif., developer of a bronchial device for asthma treatment, raised $50 million by selling a 15% stake to Olympus Medical Systems, a unit of Japan’s camera and precision-device maker Olympus.
Last October, Asthmatx withdrew an IPO at the last minute, citing a… Continue Reading
Boston Scientific acquires Endotex, the latest exit for serial entrepreneur Khosravi
Boston Scientic has acquired Cupertino stent maker, Endotex, for an undisclosed amount.
Endotex had raised more than $25 million in venture funding, including from Delphi Ventures, Guidant Corp., New Enterprise Associates, New Venture Partners, Onset Ventures, US Surgical and Saratoga Ventures. Boston Scientific had also owned… Continue Reading